Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Ketamine Hydrochloride in Vaso-occlusive crisis: NCT07682662 Clinical Landscape Report 2026
11 September 2026
NCT07682662 clinical landscape for Vaso-occlusive crisis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
9 min read
CRT-402 in Myositis: NCT07778446 Clinical Landscape Report 2026
11 September 2026
NCT07778446 clinical landscape for Myositis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
9 min read
Tirzepatide in Endometrioid intraepithelial neoplasia: NCT07812636 Clinical Landscape Report 2026
11 September 2026
NCT07812636 clinical landscape for Endometrioid intraepithelial neoplasia: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
Read →
9 min read
Carboplatin in Triple Negative Breast Cancer: NCT07786428 Clinical Landscape Report 2026
11 September 2026
NCT07786428 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
9 min read
MRT-6160 in Arthritis, Psoriatic: NCT07801495 Clinical Landscape Report 2026
11 September 2026
NCT07801495 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
9 min read
Casdatifan in Renal Cell Carcinoma: NCT07748988 Clinical Landscape Report 2026
11 September 2026
NCT07748988 clinical landscape for Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
9 min read
SOT-106 in Metastatic osteosarcoma: NCT07801222 Clinical Landscape Report 2026
11 September 2026
NCT07801222 clinical landscape for Metastatic osteosarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
9 min read
Tezepelumab in Severe asthma: NCT07363642 Clinical Landscape Report 2026
11 September 2026
NCT07363642 clinical landscape for Severe asthma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
9 min read
SKB-571 in Pancreatic Cancer: NCT07814066 Clinical Landscape Report 2026
11 September 2026
NCT07814066 clinical landscape for Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
9 min read
JANX-007 in Metastatic castration-resistant prostate cancer: NCT07813637 Clinical Landscape Report 2026
11 September 2026
NCT07813637 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
Read →
9 min read
HRS-1597 in Obesity: NCT07808918 Clinical Landscape Report 2026
11 September 2026
NCT07808918 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
9 min read
Bevacizumab biosimilar (Bio-Thera Solutions) in Platinum-Resistant Primary Peritoneal Carcinoma: NCT07811271 Clinical Landscape Report 2026
11 September 2026
NCT07811271 clinical landscape for Platinum-Resistant Primary Peritoneal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and develop…
Read →
<
1
<<
1000
1001
1002
1003
1004
>>
2926
>